Zealand Pharma A/S American Depositary Shares
ZEAL
ZEAL was delisted on the 29th of September, 2022.
14 hedge funds and large institutions have $22M invested in Zealand Pharma A/S American Depositary Shares in 2021 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 3 closing their positions.
67% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 3
13% less funds holding
Funds holding: 16 → 14 (-2)
44% less capital invested
Capital invested by funds: $39.5M → $22M (-$17.5M)
67% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
+$4.54M |
| 2 |
BlackRock
New York
|
+$33K |
| 3 |
Morgan Stanley
New York
|
+$13.9K |
| 4 |
S
SignatureFD
Atlanta,
Georgia
|
+$5.03K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$3.43K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$20.4M |
| 2 |
Jane Street
New York
|
-$668K |
| 3 |
OMC
Old Mission Capital
Chicago,
Illinois
|
-$370K |
| 4 |
JP Morgan Chase
New York
|
-$26K |
| 5 |
PA
Parallel Advisors
San Francisco,
California
|
-$2K |
ZEAL Hedge Fund Activity: Q3 2021 in Review
14 of the 5,728 institutional investors tracked by Wall St. Rank reported a position in Zealand Pharma A/S American Depositary Shares (ZEAL) for Q3 2021, worth a combined $22M — down 44% from $39.5M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of ZEAL and 1 opened new positions — a net loss of 2 holders — while 3 trimmed existing stakes and 5 added.
The largest buyer was Bank of America, adding an estimated $4.54M. The largest seller was Wellington Management Group, cutting an estimated $20.4M.
- 14 institutional investors held Zealand Pharma A/S American Depositary Shares (ZEAL) as of Q3 2021, down from 16 in Q2 2021.
- Funds reported $22M of Zealand Pharma A/S American Depositary Shares stock for Q3 2021, down 44% quarter-over-quarter.
- 1 fund opened new Zealand Pharma A/S American Depositary Shares positions in Q3 2021 and 3 closed out, a net change of -2 holders.
- The largest Zealand Pharma A/S American Depositary Shares buyer in Q3 2021 was Bank of America, an estimated $4.54M added.
- The largest Zealand Pharma A/S American Depositary Shares seller in Q3 2021 was Wellington Management Group, an estimated $20.4M sold.
Based on aggregated 13F filings for Q3 2021.